Addressing Disparities and Variations in Care in GU Oncology

Addressing Disparities and Variations in Care in GU Oncology CME Available: auau.auanet.org/node/37337 Host: Jay D. Raman, MD, FACS Guests: Kelvin Moses, MD, PhD and Svetlana Avulova, MD LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Discuss the impact of race and cultural barriers on optimal GU cancer care. 2. Evaluate financial toxicity as a barrier to optimal patient care in urologic cancer. 3. Incorporate culturally sensitive communications to ensure quality care and reduce biases across diverse patient populations. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme